Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

N-Acetylcysteine (NAC) is a powerful antioxidant and immune-supporting compound with broad health benefits. From clearing lung congestion and reducing inflammation to enhancing brain function and ...

Oslo-based Tribune Therapeutics has raised $40 million to advance its way of inhibiting the formation of scar tissue in disease. The cash from investors including LifeArc Ventures, Novo Holdings, and ...

The following is a summary of "Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...

In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch ... to modify the progression of chronic obstructive pulmonary disease (“COPD”), is undergoing ...

The investigators searched the American version of YouTube for videos in English, from 2004 to July 2024, concerning PR on non-COPD conditions (such as interstitial lung disease, pulmonary arterial ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

6 The other four subtypes identified comprise senile emphysema, obstructive combined pulmonary fibrosis and emphysema (CPFE), restrictive CPFE and ‘vanishing lung’ emphysema. Participants of the sixth ...